Literature DB >> 25785343

Management of priapism in adult men.

Onyeanunam N Ekeke1, Hannah E Omunakwe, Ndu Eke.   

Abstract

This study aims to present the management of priapism in adult men in Port Harcourt, Nigeria. All patients who presented with priapism in 2 hospitals in Port Harcourt from July 2007 to April 2014 were prospectively studied. Treatment was assigned based on clinical presentation. Data analyzed included: age on clinical presentation, risk factor, mode, and outcome of management. There were 18 patients aged 17 to 60 years (median age: 30 years). Three patients (16.7%) presented with stuttering priapism. Most of the patients presented after 24 hours of onset. Sixteen patients (89.9%) had hematological disorders. Five patients (27.8%) took suspected aphrodisiac medications. Seven patients (38.9%) were managed conservatively. The rest achieved detumescence following glandulo-cavernous shunting. Erectile function after treatment was satisfactory in 5 patients (27.8%). The commonest cause of priapism in Port Harcourt was hematological disorder. Most of the patients presented late. Prevalence of erectile dysfunction after treatment was high.

Entities:  

Keywords:  Priapism; Sickle cell anemia; Tumescence

Mesh:

Year:  2015        PMID: 25785343      PMCID: PMC4370551          DOI: 10.9738/INTSURG-D-13-00223.1

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  27 in total

Review 1.  Priapism. From Priapus to the present time.

Authors:  S E Pautler; G B Brock
Journal:  Urol Clin North Am       Date:  2001-05       Impact factor: 2.241

2.  Outcome of management of acute prolonged priapism in patients with homozygous sickle cell disease.

Authors:  F O Adetayo
Journal:  West Afr J Med       Date:  2009 Jul-Aug

3.  Clitoral priapism: a rare condition presenting as a cause of vulvar pain.

Authors:  Carlos A Medina
Journal:  Obstet Gynecol       Date:  2002-11       Impact factor: 7.661

4.  Low-flow priapism: risk factors for erectile dysfunction.

Authors:  M S El-Bahnasawy; A Dawood; A Farouk
Journal:  BJU Int       Date:  2002-02       Impact factor: 5.588

Review 5.  Adrenergic α-blockers: an infrequent and overlooked cause of priapism.

Authors:  S J T Spagnul; P H O Cabral; D O Verndl; S Glina
Journal:  Int J Impot Res       Date:  2011-05-19       Impact factor: 2.896

6.  Priapism in adult Nigerians.

Authors:  A E Aghaji
Journal:  BJU Int       Date:  2000-03       Impact factor: 5.588

7.  Hemolysis-associated priapism in sickle cell disease.

Authors:  Vikki G Nolan; Diego F Wyszynski; Lindsay A Farrer; Martin H Steinberg
Journal:  Blood       Date:  2005-06-28       Impact factor: 22.113

8.  Priapism in southwestern Nigeria.

Authors:  T A Badmus; I A Adediran; A R K Adesunkanmi; I A Katung
Journal:  East Afr Med J       Date:  2003-10

Review 9.  Medical and surgical management of priapism.

Authors:  J Cherian; A R Rao; A Thwaini; F Kapasi; I S Shergill; R Samman
Journal:  Postgrad Med J       Date:  2006-02       Impact factor: 2.401

10.  Priapism induced by chlorpromazine and trazodone: mechanism of action.

Authors:  J C Abber; T F Lue; J A Luo; K P Juenemann; E A Tanagho
Journal:  J Urol       Date:  1987-05       Impact factor: 7.450

View more
  5 in total

1.  Comparison of outcomes in malignant vs. non-malignant ischemic priapism: 12-year experience from a tertiary center.

Authors:  Manoj Kumar; Gaurav Garg; Ashish Sharma; Siddharth Pandey; Manmeet Singh; Satya Narayan Sankhwar
Journal:  Turk J Urol       Date:  2019-02-20

Review 2.  What is the effectiveness of surgical and non-surgical therapies in the treatment of ischemic priapism in patients with sickle cell disease? A systematic review by the EAU Sexual and Reproductive Health Guidelines Panel.

Authors:  S Minhas; A Salonia; M Gül; B Luca; K Dimitropoulos; P Capogrosso; U Milenkovic; A Cocci; R Veeratterapillay; G Hatzichristodoulou; V Modgil; G I Russo; T Tharakan; A Kalkanli; M I Omar; C Bettocchi; J Carvalho; G Corona; T H Jones; A Kadioglu; J I Martinez-Salamanca; E C Serefoglu; P Verze
Journal:  Int J Impot Res       Date:  2022-08-08       Impact factor: 2.408

3.  [Prophylaxis of recurring low-flow priapism : Experimental botulinum neurotoxin injection into the ischiocavernosus muscle].

Authors:  G Reichel; A Stenner
Journal:  Urologe A       Date:  2018-01       Impact factor: 0.639

4.  Prevalence of priapism in individuals with sickle cell disease and implications on male sexual function.

Authors:  Mateus Andrade Alvaia; Heros Aureliano Antunes da Silva Maia; Alana de Medeiros Nelli; Carina Oliveira Silva Guimarães; Evanilda Souza de Santana Carvalho; José Murillo Bastos Netto; Eduardo de Paula Miranda; Cristiano Mendes Gomes; José de Bessa Júnior
Journal:  Einstein (Sao Paulo)       Date:  2020-04-22

5.  Management of acute sickle cell priapism in an African (Togo) pediatric department includes conservative measures and intracavernous epinephrine which is safe and efficacious.

Authors:  Koffi Mawuse Guedenon; Mawouto Fiawoo; Djatougbe Ayaovi Elie Akolly; Etse Akpako; Balakibawi Esso; Fidèle Comlan Dossou; Adama Dodji Gbadoe
Journal:  EJHaem       Date:  2022-04-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.